Elicio Therapeutics, Inc.
ELTX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $183 | $124 | $80 | $62 |
| - Cash | $21 | $22 | $18 | $18 |
| + Debt | $5 | $15 | $6 | $26 |
| Enterprise Value | $167 | $117 | $67 | $71 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | $0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$9 | -$10 | -$11 | -$13 |
| % Margin | – | – | – | – |
| Net Income | -$10 | -$11 | -$11 | -$14 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.6 | -0.66 | -0.87 | -1.15 |
| % Growth | 9.1% | 24.1% | 24.3% | – |
| Operating Cash Flow | -$11 | -$9 | -$10 | -$9 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$11 | -$9 | -$10 | -$9 |